Medikonics will leverage TechBizAI’s cutting-edge artificial intelligence capabilities to offer unparalleled insights and strategies in IP management. The new division aims to empower inventors, researchers, and businesses by providing sophisticated analysis, strategic planning, and comprehensive solutions for IP development and monetization, particularly in health tech industry.
“Medikonics represents a significant milestone in our mission to harness the power of AI for the betterment of intellectual property management,” said Dr. Rahat Ali, CEO of TechBizAI. “With this new division, we are not only expanding our portfolio but also enhancing our ability to meet the diverse needs of our clients in the space of IP.”
The launch of Medikonics comes at a time when the importance of effective IP strategy and management is at an all-time high. Innovators and companies across industries face the challenge of managing complex IP landscapes to protect and leverage their inventions. Medikonics aims to address these challenges by offering state-of-the-art research, analytics, and strategic services designed to maximize the value of IP assets.
Medikonics services will include IP landscape analysis, technology assessments, monetization strategy development, and competitive intelligence. With a focus on innovation and client-centric solutions, Medikonics is poised to become a leading force in the field of IP monetization and analytics in this AI-led era.
For more information about Medikonics and its services, please visit https://medikonics.com.
About TechBizAI
TechBizAI is a pioneering AI intelligence company committed to delivering advanced AI-driven solutions across various sectors. With a focus on innovation and excellence, TechBizAI leverages artificial intelligence to provide actionable insights, enhance decision-making, and drive success for businesses worldwide.
Contact Information:
Dr. Rahat Ali
CEO
TechBizAI
contact@techbizai.com
+1-917-675-3345
https://techbizai.com
